Table 2 Discontinuance criteria

Serum UA >12.0 mg/dL

Onset of gout arthritis

Considered inappropriate to continue the study by investigators due to adverse side effects or serious adverse events

Needed to receive any prohibited concomitant drugs

Participant relocated or changed doctor

The participant decides they no longer wish to continue the study

Considered inappropriate to continue the study by investigators due to some other reason